BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 29508099)

  • 1. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
    Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W
    Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.
    Takahashi M; Oda Y; Okubo T; Shirayama Y
    J Neural Transm (Vienna); 2017 Sep; 124(9):1109-1121. PubMed ID: 28509077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine.
    Shirayama Y; Takahashi M; Oda Y; Yoshino K; Sato K; Okubo T; Iyo M
    Brain Imaging Behav; 2019 Feb; 13(1):75-86. PubMed ID: 29247294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between blood flow kinetics and severity of Alzheimer's disease: assessment of severity using a questionnaire-type examination, Alzheimer's disease assessment scale, cognitive sub-scale (ADAS(cog)).
    Nebu A; Ikeda M; Fukuhara R; Shigenobu K; Maki N; Hokoishi K; Komori K; Yasuoka T; Tanabe H
    Dement Geriatr Cogn Disord; 2001; 12(5):318-25. PubMed ID: 11455133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease.
    Yoshida T; Ha-Kawa S; Yoshimura M; Nobuhara K; Kinoshita T; Sawada S
    Ann Nucl Med; 2007 Jul; 21(5):257-65. PubMed ID: 17634843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT-identified neuroanatomical predictor of the cognitive effects of donepezil treatment in patients with Alzheimer's disease.
    Hongo J; Nakaaki S; Shinagawa Y; Murata Y; Sato J; Tatsumi H; Tohyama J; Soma T; Iidaka T; Fukui T; Mimura M; Furukawa TA
    Dement Geriatr Cogn Disord; 2008; 26(6):556-66. PubMed ID: 19066429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    Tai H; Hirano S; Sakurai T; Nakano Y; Ishikawa A; Kojima K; Li H; Shimada H; Kashiwado K; Mukai H; Horikoshi T; Sugiyama A; Uno T; Kuwabara S
    J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
    Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPECT follow-up study of cerebral blood flow changes during Donepezil therapy in patients with Alzheimer's disease.
    Shimizu S; Hanyu H; Iwamoto T; Koizumi K; Abe K
    J Neuroimaging; 2006 Jan; 16(1):16-23. PubMed ID: 16483272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis.
    Waragai M; Mizumura S; Yamada T; Matsuda H
    Dement Geriatr Cogn Disord; 2008; 26(6):547-55. PubMed ID: 19066428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease.
    Rodriguez G; Vitali P; Canfora M; Calvini P; Girtler N; De Leo C; Piccardo A; Nobili F
    Clin Neurophysiol; 2004 Jan; 115(1):39-49. PubMed ID: 14706467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study.
    Hanyu H; Sato T; Hirao K; Kanetaka H; Iwamoto T; Koizumi K
    J Neurol Sci; 2010 Mar; 290(1-2):96-101. PubMed ID: 19931870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
    Soininen H; Helkala EL; Kuikka J; Hartikainen P; Lehtovirta M; Riekkinen PJ
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):95-109. PubMed ID: 8527009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT.
    Bartenstein P; Minoshima S; Hirsch C; Buch K; Willoch F; Mösch D; Schad D; Schwaiger M; Kurz A
    J Nucl Med; 1997 Jul; 38(7):1095-101. PubMed ID: 9225797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a high dosage of donepezil for Alzheimer's disease as examined by single-photon emission computed tomography imaging.
    Kanaya K; Abe S; Sakai M; Fujii H; Koizumi K; Iwamoto T
    Psychogeriatrics; 2012 Sep; 12(3):172-8. PubMed ID: 22994615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease.
    Nakano S; Asada T; Matsuda H; Uno M; Takasaki M
    J Nucl Med; 2001 Oct; 42(10):1441-5. PubMed ID: 11585854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3DSRT evaluation of responses of Alzheimer type dementia to donepezil hydrochloride therapy.
    Higashiyama S; Kawabe J; Hashimoto H; Akiyama H; Kawamura E; Torii K; Inoue K; Kiriike N; Shiomi S; Inoue Y
    Osaka City Med J; 2006 Dec; 52(2):55-62. PubMed ID: 17330392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular risk factors and the relationships between cognitive impairment and hypoperfusion in late-onset Alzheimer's disease.
    Takahashi M; Oda Y; Sato K; Shirayama Y
    Acta Neuropsychiatr; 2018 Dec; 30(6):350-358. PubMed ID: 30132427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in regional cerebral blood flow in the right cortex homologous to left language areas are directly affected by left hemispheric damage in aphasic stroke patients: evaluation by Tc-ECD SPECT and novel analytic software.
    Uruma G; Kakuda W; Abo M
    Eur J Neurol; 2010 Mar; 17(3):461-9. PubMed ID: 19922460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.